INMB vs AAPL: Which Stock is Better?
Side-by-side comparison of Inmune Bio Inc and Apple Inc in 2026
INMB
Inmune Bio Inc
$1.29
AAPL
Apple Inc
$258.74
Key Metrics Comparison
| Metric | INMB | AAPL | Winner |
|---|---|---|---|
| Market Cap | $31.37M | N/A | INMB |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 2.6% | 0.2% | INMB |
| Gross Margin | 100.0% | 47.3% | INMB |
Analyze INMB
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INMB or AAPL a better investment?
Comparing INMB and AAPL: Inmune Bio Inc has a market cap of $31.37M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INMB and AAPL?
INMB (Inmune Bio Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INMB or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INMB or AAPL?
INMB has higher revenue growth at 2.6% vs 0.2% for AAPL.
Which company is more profitable: INMB or AAPL?
Inmune Bio Inc (INMB) has higher gross margins at 100.0% compared to 47.3% for AAPL.
Which is the larger company: INMB or AAPL?
Inmune Bio Inc (INMB) is larger with a market cap of $31.37M compared to N/A for AAPL.
Should I buy INMB or AAPL in 2026?
Both INMB and AAPL have investment merit. INMB trades at $1.29 while AAPL trades at $258.74. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INMB and AAPL stock?
Key differences: Market Cap ($31.37M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (2.6% vs 0.2%), Gross Margin (100.0% vs 47.3%).